作者
Matthew C Riddle, William T Cefalu, Philip H Evans, Hertzel C Gerstein, Michael A Nauck, William K Oh, Amy E Rothberg, Carel W le Roux, Francesco Rubino, Philip Schauer, Roy Taylor, Douglas Twenefour
发表日期
2022/1/1
来源
The Journal of Clinical Endocrinology & Metabolism
卷号
107
期号
1
页码范围
1-9
出版商
Oxford University Press
简介
Improvement of glucose levels into the normal range can occur in some people living with diabetes, either spontaneously or after medical interventions, and in some cases can persist after withdrawal of glucose-lowering pharmacotherapy. Such sustained improvement may now be occurring more often due to newer forms of treatment. However, terminology for describing this process and objective measures for defining it are not well established, and the long-term risks versus benefits of its attainment are not well understood. To update prior discussions of this issue, an international expert group was convened by the American Diabetes Association to propose nomenclature and principles for data collection and analysis, with the goal of establishing a base of information to support future clinical guidance. This group proposed “remission” as the most appropriate descriptive term, and HbA1c < 6.5% (48 mmol …
引用总数
学术搜索中的文章
MC Riddle, WT Cefalu, PH Evans, HC Gerstein… - The Journal of Clinical Endocrinology & Metabolism, 2022